 |
|
Review 2
The Approved Avemar label
The approved label for the Avemar packaging is as follows:
Indications: Avemar is a medical nutriment for complementing cancer treatment during and after surgery, radiotherapy, chemotherapy and immune therapy. The continuous use of Avemar is recommended during the full course of clinical treatment and after its completion for as long as recommended by the treating physician. After surgery, the administration of Avemar can begin when the patient has been able to take food orally and without complications for at least 4 days.
Side effects: The use of Avemar produces, on rare occasions, a soft stool and, on even rarer occasions, an unsettled stomach or nausea.
Contraindications: Avemar should not be taken during pregnancy and breastfeeding. Avemar should not be taken by patients undergoing organ or tissue transplants, or those who suffer from bleeding erosions and/or bleeding ulcers of the gastrointestinal tract (bleeding stomach and bleeding duodenal ulcers), enteritis/colitis (serious inflammations of the gastro-intestinal tract), or malabsorption syndrome (sprue), including gluten sensitive enteropathies (celiac sprue). Patients with inherited fructose intolerance or patients with hypersensitivity to any components or ingredients of Avemar should also avoid its use.
Known interactions with other drugs: If vitamin C is being ad-ministered, Avemar should be consumed at least 2 hours before or after treatments with preparations containing vitamin C. As Avemar may adversely affect the absorption of other medications or supplements, Avemar should be taken at least 2 hours before or after treatments using other products.
Warning: Avemar is not a replacement or substitute for clinically indicated anti-cancer therapies and procedures. Keep out of reach of children. The medication should only be taken under medical supervision, for patients of 14 years and older. The use of Avemar should be discontinued 2 days before barium sulfate X-ray contrast examinations and should not be reinstated within 2 days after the completion of the examination! Patients with dia-betes can take Avemar under the supervision of a health professional, but the product's carbohydrate content must be taken into consideration.
Preparation, dosage and administration:
Preparation of a single dose:
The measuring spoon included with the product measures out single doses (9 g). Mix one level measuring spoonful of Avemar with 150 ml of cold water and drink it.
Once the Avemar solution has been made, it should be used within 30 minutes. Any unused solution should be discarded.
Dosage: For an adult of average weight (~70 kg), a single daily dose of 9g, prepared according to the above instructions, is recommended, ideally approximately 1 hour before eating. Pa-tients with a body weight of 90 kg or more should consume two 9 g doses per day, ideally 1 hour before breakfast and supper.
Avemar can also be prepared and consumed in soft drinks or non-carbonated mineral water, providing that their vitamin C (as-corbic acid or E 300) content is not significant.
|
 |
|
 |
